Literature DB >> 3115979

Differential effects of gamma-interferon on collagen and fibronectin gene expression.

M J Czaja1, F R Weiner, M Eghbali, M A Giambrone, M Eghbali, M A Zern.   

Abstract

The interferons are a group of endogenous proteins that exhibit a variety of biological functions in addition to their ability to induce resistance to viruses. In order to evaluate the anti-fibrogenic actions of interferon, we have delineated the level of regulation responsible for gamma-interferon-induced changes in collagen and fibronectin gene expression in cultured fibroblasts. Confluent human skin fibroblasts were exposed to 500 anti-viral units/ml of gamma-interferon. RNA was then extracted from the cells, and steady-state mRNA levels were determined by Northern and dot blot hybridization studies. Cells exposed to interferon had type I procollagen mRNA levels that were 23% of control and type III procollagen mRNA levels only 7% of control. The interferon-treated cells also had beta-actin mRNA levels that were decreased to 51% that of untreated cells but had fibronectin steady-state mRNA levels that were 560% of control levels. Nuclear run-on assays revealed that interferon did not affect the transcriptional rates of types I and III collagen or beta-actin, but it did increase the transcriptional rate of fibronectin to 670% of control levels. These findings demonstrate that gamma-interferon causes a marked decrease in types I and III procollagen mRNA levels in vitro by a post-transcriptional mechanism while inducing fibronectin expression at a transcriptional level.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3115979

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Liposome associated interferon-alpha-2b functions as an anti-fibrogenic factor in dermal wounds in the guinea pig.

Authors:  A Ghahary; E E Tredget; Q Shen; R T Kilani; P G Scott; M Takeuchi
Journal:  Mol Cell Biochem       Date:  2000-05       Impact factor: 3.396

Review 2.  Current and future anti-fibrotic therapies for chronic liver disease.

Authors:  Don C Rockey
Journal:  Clin Liver Dis       Date:  2008-11       Impact factor: 6.126

3.  In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung diseases.

Authors:  C Prior; P L Haslam
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

4.  The rat hepatocyte plasma membrane organic anion binding protein is immunologically related to the mitochondrial F1 adenosine triphosphatase beta-subunit.

Authors:  T Goeser; R Nakata; L F Braly; A Sosiak; C G Campbell; R Dermietzel; P M Novikoff; R J Stockert; R D Burk; A W Wolkoff
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

5.  Adeno-associated virus mediated interferon-gamma inhibits the progression of hepatic fibrosis in vitro and in vivo.

Authors:  Miao Chen; Guang-Ji Wang; Yong Diao; Rui-An Xu; Hai-Tang Xie; Xin-Yan Li; Jian-Guo Sun
Journal:  World J Gastroenterol       Date:  2005-07-14       Impact factor: 5.742

6.  Human papillomavirus type 16 E7 oncoprotein represses transcription of human fibronectin.

Authors:  O Rey; S Lee; N H Park
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

7.  Differential regulation of glycosaminoglycan, fibronectin, and collagenase production in cultured human dermal fibroblasts by interferon-alpha, -beta, and -gamma.

Authors:  M R Duncan; B Berman
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

8.  Effect of angiotensin-converting enzyme inhibition on experimental hepatic fibrogenesis.

Authors:  Cansel Türkay; Ozlem Yönem; Sema Arici; Ayhan Koyuncu; Mehmet Kanbay
Journal:  Dig Dis Sci       Date:  2007-09-01       Impact factor: 3.199

9.  Effects of a 24-week course of interferon-alpha therapy after curative treatment of hepatitis C virus-associated hepatocellular carcinoma.

Authors:  Soo Cheol Jeong; Hiroshi Aikata; Yoshio Katamura; Takahiro Azakami; Tomokazu Kawaoka; Hiromi Saneto; Kiminori Uka; Nami Mori; Shintaro Takaki; Hideaki Kodama; Koji Waki; Michio Imamura; Hiroo Shirakawa; Yoshiiku Kawakami; Shoichi Takahashi; Kazuaki Chayama
Journal:  World J Gastroenterol       Date:  2007-10-28       Impact factor: 5.742

10.  Effects of tumor necrosis factor-alpha on connective tissue metabolism in normal and scleroderma fibroblast cultures.

Authors:  K Takeda; A Hatamochi; M Arakawa; H Ueki
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.